Fourthly, PI3K/Akt also activates the downstream regulator of the mammalian target of rapamycin (mTOR) to further activate HIF-1α, so as to promote aerobic glycolysis, angiogenesis and neo-vascularization in cancer cells [18]. Here, AKT1 is linked to cancer.